By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ideon Science and Technology Park
Sölvegatan 41
Lund    S-223 70  Sweden
Phone: 46-46-286-8550 Fax: 46-46-211-0806



Drug Discovery

Company News
BioInvent (BOVNF): Resolution At BioInvent’s Annual General Meeting 2016 5/13/2016 9:36:59 AM
BioInvent (BOVNF)’s Board Director Dharminder Chahal Increases His Shareholding In The Company 5/6/2016 9:27:44 AM
BioInvent (BOVNF), Oncurious And NMTRC Initiating Phase I/IIa Study With TB-403 For The Treatment Of Medulloblastoma 5/2/2016 8:56:46 AM
BioInvent (BOVNF) Interim Report 1 January – 31 March 2016 4/26/2016 12:31:01 PM
Multiple Myeloma Phase II Study Of BioInvent (BOVNF)'s Antibody BI-505 Ready To Start 4/18/2016 11:24:50 AM
BioInvent (BOVNF)’s Rights Issue Completed 4/15/2016 9:59:03 AM
BioInvent (BOVNF): Annual Report 2015 3/23/2016 10:06:10 AM
Resolutions Of The Extraordinary General Meeting Of BioInvent (BOVNF) 3/18/2016 10:57:48 AM
BioInvent (BOVNF) Is Granted A Patent In Europe For The Immune-Oncology Antibody BI-505 3/16/2016 9:31:44 AM
BioInvent (BOVNF) And Oncurious Partner With US Research Consortium To Accelerate Phase I/IIa Trial Of TB-403 3/15/2016 9:13:59 AM